These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17289747)

  • 21. Platelet inhibition with cangrelor.
    Ruparelia N; Spyrou N
    N Engl J Med; 2010 Mar; 362(11):1048-9; author reply 1049. PubMed ID: 20237353
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins do not affect platelet inhibition with clopidogrel during coronary stenting.
    Serebruany VL; Malinin AI; Callahan KP; Gurbel PA; Steinhubl SR
    Atherosclerosis; 2001 Nov; 159(1):239-41. PubMed ID: 11689228
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 25. High postclopidogrel platelet reactivity in non-ST-elevation acute coronary syndrome treated with stenting: a clue for adverse prognosis?
    Galvani M
    J Thromb Haemost; 2006 Mar; 4(3):536-8. PubMed ID: 16460436
    [No Abstract]   [Full Text] [Related]  

  • 26. Consider this: It's too little!
    Block PC
    Catheter Cardiovasc Interv; 2000 Jul; 50(3):280-1. PubMed ID: 10878622
    [No Abstract]   [Full Text] [Related]  

  • 27. Clopidogrel use in coronary heart disease and percutaneous coronary intervention.
    Atiemo AD; Williams MS
    J Investig Med; 2008 Apr; 56(4):689-700. PubMed ID: 18382265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The GRAVITAS study].
    Rollini F; Angiolillo DJ; Cattaneo M
    G Ital Cardiol (Rome); 2012 Jan; 13(1):1-5. PubMed ID: 22322466
    [No Abstract]   [Full Text] [Related]  

  • 31. Clopidogrel and stent thrombosis after percutaneous coronary intervention.
    Gladding P; Webster M
    N Z Med J; 2007 Jun; 120(1255):U2554. PubMed ID: 17546102
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
    Sibbing D; Bernlochner I; Schulz S; Massberg S; Schömig A; Mehilli J; Kastrati A
    J Am Coll Cardiol; 2012 Jul; 60(5):369-77. PubMed ID: 22682553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
    Lansky AJ; Tsuchiya Y; Brener M; Mehran R; Cristea E; Pietras C; Grines CL; Cox DA; Garcia E; Tcheng JE; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Leon MB; Moses J; Stone GW
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):917-24. PubMed ID: 19016469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tackling the diabetic platelet: is high clopidogrel dosing the answer?
    Angiolillo DJ
    J Thromb Haemost; 2006 Dec; 4(12):2563-5. PubMed ID: 16968328
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk reduction with long-term clopidogrel following percutaneous coronary intervention.
    Steinhubl SR; Topol EJ
    Eur Heart J; 2004 Dec; 25(23):2169-70; author reply 2170-1. PubMed ID: 15571836
    [No Abstract]   [Full Text] [Related]  

  • 36. Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both?
    Moliterno DJ; Steinhubl SR
    JAMA; 2005 Sep; 294(10):1271-3. PubMed ID: 16143697
    [No Abstract]   [Full Text] [Related]  

  • 37. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Alfonso F
    JAMA; 2007 Apr; 297(16):1769; author reply 1770-1. PubMed ID: 17456814
    [No Abstract]   [Full Text] [Related]  

  • 38. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does clopidogrel each day keep stent thrombosis away?
    Kereiakes DJ
    JAMA; 2007 Jan; 297(2):209-11. PubMed ID: 17213405
    [No Abstract]   [Full Text] [Related]  

  • 40. [Perioperative antiplatelet therapy of patients with coronary stents].
    Chatterjee T; Akin I; Rehders TC; Chatterjee A; Schüpfer C; Nienaber CA; Ince H
    Praxis (Bern 1994); 2009 Oct; 98(21):1199-210. PubMed ID: 19844878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.